PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis

NCT00005005 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

238

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: PTH
DRUG: Alendronate

Sponsor

Dennis Black

Collaborators

[object Object]